Artivion | CRY - Stammkapital





Stammkapital Veränderung Datum
Abbott USD 1.74B 23.39B 2025-09
Accuray USD 100K 1000 2024-09
AngioDynamics USD 41.57M 127K 2025-09
Artivion USD 47.84M 468K 2025-12
AtriCure USD 49.79M 91K 2025-12
Baxter International USD 516.45M 2.17M 2026-03
Becton, Dickinson and Co. USD 284.91M 1.72M 2025-12
Boston Scientific USD 1.48B 2.66M 2025-12
Edwards Lifesciences USD 580.7M 0 2025-12
Inogen USD 23K 0 2023-12
Integra LifeSciences USD 77.82M 69K 2026-03
J&J USD 2.41B 1.74M 2025-12
Mesa Laboratories USD 349.53M 3.53M 2024-09
Orthofix International USD 39.83M 315K 2025-12
Pfizer USD 5.7B 13M 2026-03
ResMed USD 190.83M 44.86M 2026-03
Stryker USD 382.98M 584K 2026-03
Tandem Diabetes Care USD 68.29M 518K 2025-12
Teleflex USD 44.26M 70K 2026-03
Terumo JPY 1.48B 11K 2026-03
Trinity Biotech USD 385.2M 382.82M 2025-06